Moderna market cap

2 days ago · Moderna (NASDAQ:MRNA) has been one of the hottest stocks to buy over the past year, soaring more than 340% while the S&P 500 has increased by just 30% during that time. The company’s COVID-19 vaccine has put Moderna on the map with investors, sending its market cap from less than $10 billion to more than $52 billion.

Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an … 305 rows MRNA:NASDAQ GS Stock Quote - Moderna Inc - Bloomberg Markets. DJIA. 31,496.30.

25.12.2020

ET by Claudia Assis Moderna Inc. stock falls Wednesday, underperforms market View the latest Moderna Inc. (MRNA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Feb 25, 2021 · Biotech and pharmaceutical company Moderna, a forerunner in the development of coronavirus vaccines, has the potential to reach a $100 billion-plus market capitalization, according to one analyst. Jul 29, 2020 · I valued Moderna at $46 per share, or a market capitalization of $17 billion. Admittedly that is more of a qualitative guess than a quantitative analysis. There are many possible forks in the road Moderna has a market capitalization of $49.36 billion and generates $60.21 million in revenue each year. The company earns $-514,020,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis.

Moderna has a market cap of $51.87 B, which represents its current share price of $129.75 multiplied by its outstanding share number of 399.77. As a large-cap

Moderna Inc is engaged in creating transformative medicines based on messenger RNA, or mRNA. It transfers the information stored in the genes to the cellular machinery that makes all the proteins required for life.

21 Jul 2020 JP Morgan cuts its rating for Moderna, saying its $37 billion market cap is way too high even if its COVID-19 vaccine mRNA-1273 succeeds in

It is equal to the share price times the number of shares outstanding. Moderna's Market Cap for the fiscal year that ended in Dec. 2020 is calculated as Comparatively, 29.2% of Moderna shares are held by company insiders.

Sep 12, 2019 · Yet after the 6-month lock up period, some investors took advantage of their ability to sell the stock, and Moderna’s market capitalization is now at $5.4 billion. As of March 2021 Moderna has a market cap of $50.35 B. This makes Moderna the world's 334th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth. Find the latest Moderna, Inc. (MRNA) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock analysis for Moderna Inc (MRNA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 52.318B. Day Range.

Beta (5Y Monthly), 1.47. PE Ratio (TTM), N/A. EPS (TTM), - 1.96. Earnings Date, May 05, 2021 - May 10, 2021. Forward Dividend & Yield Market Cap (intraday) 5. 49.36B, 41.34B, 27.97B, 25.25B, 11.08B, 6.58B. Enterprise Value 3. 44.96B, 38.28B, 25.42B, 24.18B, 10.11B, 5.56B.

Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Moderna market cap as of March 05, 2021 is $52.85B. Compare MRNA With Other Stocks 2 days ago · Moderna vaccinates first people in study to test vaccine-booster candidates Mar. 10, 2021 at 4:35 p.m. ET by Claudia Assis Moderna Inc. stock falls Wednesday, underperforms market View the latest Moderna Inc. (MRNA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Feb 25, 2021 · Biotech and pharmaceutical company Moderna, a forerunner in the development of coronavirus vaccines, has the potential to reach a $100 billion-plus market capitalization, according to one analyst. Jul 29, 2020 · I valued Moderna at $46 per share, or a market capitalization of $17 billion. Admittedly that is more of a qualitative guess than a quantitative analysis.

Cambridge, Massachusetts-based Moderna, is trying to develop a new kind of drug Market Cap:. Moderna Share Price - MRNA Moderna expects Phase 1 data for multivalent Coronavirus Vaccine sooner than May • SEEK Thursday Market Cap, $ 54.84B. 26 Feb 2020 Moderna's (MRNA.Q) “Coronavirus Vaccine” announcement – causes $3.4 billion jump in market cap. Home Health-Medicine 18 May 2020 Stocks bounced back Monday on optimism after drugmaker Moderna Forecasters warn the latest market buoyancy might be premature and a 17 Dec 2020 MRNA - Moderna Price target 12/18. 1,207 views1.2K LIVE AMC + GME - STOCK MARKET LIVE ANALYSIS & CHARTS.

With the stock closing at $69 on Friday its market cap is $25.6 Conversely, the analyst says some “valuation sensitive investors,” might be “frustrated” with Moderna’s $63 billion market cap. This no doubt means expectations are high and the lofty multiples and Market Cap, 56.262B. Beta (5Y Monthly), 1.47. PE Ratio (TTM), N/A. EPS (TTM), - 1.96.

jst coin novinky
utah ltc zmena adresy
peniaze na mojom účte, ale karta bola odmietnutá
minimálna platba tsb kreditná karta
pracuje tor v číne
najlepšia sadzba od 1 sgd do thb

In depth view into Moderna Market Cap Score including historical data from 2018, charts, stats and industry comps.

Biotech and pharmaceutical company Moderna, a pioneer in developing coronavirus vaccines, has the potential to reach a market cap of over $ 100 billion, according to an analyst. Jan 28, 2021 · This company has changed the vaccine game, but is Moderna stock worth the $65 billion market cap? By Dana Blankenhorn , InvestorPlace Contributor Jan 28, 2021, 12:03 pm EST January 28, 2021 Moderna announced Wednesday that it's going to trial a Covid-19 booster shot to target the South Africa variant. Biotech and pharmaceutical company Moderna, a forerunner in the development of coronavirus vaccines, has the potential to reach a $100 billion-plus market capitalization, according to one analyst. Feb 22, 2021 · The business has a fifty day moving average of $146.35 and a 200 day moving average of $102.79.

1/24/2021

The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

These small-cap stocks are flying under the radar. Wayne Duggan March 5, Jan 18, 2021 · After briefly becoming the state's most highly valued biotech stock, some investors are concerned Moderna’s market capitalization may be too lofty.